Paraoxonase 1 Met–Leu 54 polymorphism is associated with Parkinson’s disease
- 1 March 2001
- journal article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 184 (2) , 179-182
- https://doi.org/10.1016/s0022-510x(01)00439-7
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Gln → Arg 191 Polymorphism of Paraoxonase and Parkinson’s DiseaseHuman Heredity, 1999
- Paraoxonase PON1 Polymorphism Leu-Met54 Is Associated With Carotid AtherosclerosisStroke, 1998
- Human Serum ParaoxonaseGeneral Pharmacology: The Vascular System, 1998
- A susceptibility locus for Parkinson's disease maps to chromosome 2p13Nature Genetics, 1998
- AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's diseaseNature Genetics, 1998
- Effect of the molecular polymorphisms of human paraoxonase (PON1) on the rate of hydrolysis of paraoxonBritish Journal of Pharmacology, 1997
- Mutation in the α-Synuclein Gene Identified in Families with Parkinson's DiseaseScience, 1997
- Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes.Journal of Clinical Investigation, 1997
- Structural Organization of the HumanPON1GeneGenomics, 1996
- ParkinsonismNeurology, 1967